Why the study?
Does substrate-based catheter ablation with scar encirclement prevent recurrent VT in a patient with ischemic heart disease and slow VT storm?
Case Report (n=1)
Does substrate-based catheter ablation with scar encirclement prevent recurrent VT in a patient with ischemic heart disease and slow VT storm?
Answers are grounded in this paper and cite their sources.
Encirclement of the entire scar tissue may be an effective substrate-based ablation strategy for recurrent slow VT storm in ischemic heart disease when clinical VTs are not inducible.
We present a case of a 79-year-old man with slow ventricular tachycardia (VT) storm and ischemic heart disease despite antiarrhythmic drug therapy, implantable cardioverter defibrillator (ICD), and two VT catheter ablations. He presented with stable ischemic heart disease and a large apical aneurysm along with a left ventricular ejection fraction of 30%. We performed catheter ablation in conscious sedation. After substrate-based mapping, we identified a large scar area in the region of the aneurysm. Only the cycle length of the clinical VT was known but not inducible. Two other VTs were inducible. As the slow VTs were not accessible through the ICD due to slow heart rate, we performed an encirclement of the whole scar tissue. After that, no VTs were inducible anymore and the patient remained free of symptomatic episodes thereafter. The best strategy in substrate-based ablation is still not clear. Prospective clinical trials are needed to identify the right strategy for the right patient.
No takes yet. Share an insight, caveat, or question.
Kany et al. (2022) conducted a case report in Ischemic heart disease and recurrent ventricular tachycardia (n=1). Catheter ablation with encirclement of the whole scar tissue was evaluated on Inducibility of VTs and freedom from symptomatic episodes.
Synapse has enriched 10 related papers. Consider them for comparative context: